Literature DB >> 8641991

Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro.

M Ueda1, H Fujii, K Yoshizawa, F Abe, M Ueki.   

Abstract

Biological effects of sex steroids (estradiol-17beta, E2; progesterone, P; medroxyprogesterone acetate, MPA; Danazol, DZ) and growth factors (epidermal growth factor, EGF; transforming growth factor, TGF-alpha,beta) on migration and invasion of endometrial adenocarcinoma SNG-M cells were investigated by haptotactic migration and haptoinvasion assay. The enzymatic degradation of the extracellular matrix by tumor cells was also examined. Tumor cell migration along a gradient of substratum-bound fibronectin was inhibited by 0.1-10 microM MPA and DZ, but promoted by 0.1-10 nM EGF and TGF-alpha in a concentration-dependent manner. E2, P and TGF-beta did not have any effect on the motility of tumor cells. These effects were also confirmed by wound assay. The invasive activity of SNG-M cells into reconstituted basement membrane (Matrigel) was inhibited by the presence of 0.1-10 microM MPA and DZ, but promoted by 0.1-10 nM EGF and TGF-alpha in a concentration-dependent manner. E2, P and TGF-beta did not have any effect on tumor cell invasion. The zymography of tumor-conditioned medium showed that the treatment of SNG-M cells with EGF and TGF-alpha resulted in the increase of the 68, 72 and 92 kDa type IV collagenases (matrix metalloproteinase, MMP-2 and 9). Sex steroids and TGF-beta did not have significant effects on MMP-2 and 9. Stromelysin (MMP-3), also secreted by SNG-M cells, was not affected by sex steroids and growth factors. These results suggest that EGF and TGF-alpha act as positive regulators on the invasion process of endometrial adenocarcinoma cells, which may partly be associated with the induction of type IV collagenase secretion by tumor cells. The inhibitory effects of MPA and DZ on tumor cell invasion may depend at least partly on their inhibitory action on the motility of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641991      PMCID: PMC5921127          DOI: 10.1111/j.1349-7006.1996.tb00255.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  40 in total

1.  Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma.

Authors:  I Ishiwata; S Nozawa; T Inoue; H Okumura
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

2.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

3.  Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary.

Authors:  T Yamada; M Ueda; Y Otsuki; M Ueki; O Sugimoto
Journal:  Gynecol Oncol       Date:  1991-02       Impact factor: 5.482

Review 4.  Current status of estrogen and progesterone receptors in breast cancer.

Authors:  W L McGuire; K B Horwitz; O H Pearson; A Segaloff
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

5.  Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro.

Authors:  J B McCarthy; L T Furcht
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

6.  Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors.

Authors:  M Nakajima; A M Chop
Journal:  Semin Cancer Biol       Date:  1991-04       Impact factor: 15.707

Review 7.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.

Authors:  B F Sloane; K V Honn; J G Sadler; W A Turner; J J Kimpson; J D Taylor
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

9.  Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.

Authors:  A Kauppila; H Isotalo; S Kivinen; F Stenbäck; R Vihko
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

10.  Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas.

Authors:  K Yoshida; H Yokozaki; M Niimoto; H Ito; M Ito; E Tahara
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

View more
  8 in total

1.  Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.

Authors:  Nikki L Neubauer; Erin C Ward; Parin Patel; Zhenxiao Lu; Irene Lee; Leen J Blok; Payman Hanifi-Moghaddam; Julian Schink; J Julie Kim
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

Review 2.  Progesterone receptor action in leiomyoma and endometrial cancer.

Authors:  J Julie Kim; Elizabeth C Sefton; Serdar E Bulun
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

Review 3.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

Review 4.  Role of progesterone in endometrial cancer.

Authors:  J Julie Kim; Eloise Chapman-Davis
Journal:  Semin Reprod Med       Date:  2010-01-26       Impact factor: 1.303

5.  Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.

Authors:  R Hasina; K Matsumoto; N Matsumoto-Taniura; I Kato; M Sakuda; T Nakamura
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

6.  Effects of epidermal growth factor on the invasive activity and cytoskeleton of oral squamous cell carcinoma cell lines.

Authors:  Yuichi Ohnishi; Masahiro Watanabe; Hiroki Yasui; Kenji Kakudo
Journal:  Oncol Lett       Date:  2014-03-07       Impact factor: 2.967

7.  Effects of sex steroids and growth factors on invasive activity and 5'-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells.

Authors:  M Ueda; H Fujii; K Yoshizawa; K Kumagai; K Ueki; Y Terai; T Yanagihara; M Ueki
Journal:  Jpn J Cancer Res       Date:  1998-12

8.  Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.

Authors:  M Ueda; K Kitaura; O Kusada; Y Mochizuki; N Yamada; Y Terai; K Kumagai; K Ueki; M Ueki
Journal:  Jpn J Cancer Res       Date:  2000-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.